PAK Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine umfassende Sammlung von PAK-Antikörpern für die Untersuchung von p21-aktivierten Kinasen (PAKs) in verschiedenen zellulären Prozessen. PAK-Antikörper sind validiert für Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzymimmunoassay (ELISA).PAKs sind Serin/Threonin-Kinasen, die Zellmorphologie, Motilität und Überleben regulieren. PAKs sind an Signalwegen beteiligt, die Reaktionen auf Wachstumsfaktoren und Stress vermitteln, was sie zu wichtigen Zielen in der Krebsforschung und bei anderen Krankheiten macht. Das Verständnis der PAK-Funktionen kann neue therapeutische Möglichkeiten für verschiedene Erkrankungen eröffnen. Die Forschung hat gezeigt, dass PAKs die Dynamik des Zytoskeletts und die Zelladhäsion beeinflussen. PAK-Signalnetzwerke sind für die normale zelluläre Entwicklung und die Aufrechterhaltung des Gewebes von wesentlicher Bedeutung. Jüngste Studien haben gezeigt, dass PAK bei neurologischen Erkrankungen und der Regulierung des Immunsystems eine Rolle spielen. Die monoklonalen Antikörper von Santa Cruz Biotechnology ermöglichen es Forschern, das wissenschaftliche Verständnis der PAK-Biologie voranzutreiben und zur Entwicklung gezielter Therapien beizutragen.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
PAK Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
α/β/γPAK Antikörper (D-8) | sc-166174 | mouse IgG1 κ | 263-345 (m) | WB, IP, IF, IHC(P), ELISA | m, r, h | 6 | ||
αPAK Antikörper (A-6) | sc-166887 | mouse IgG1 κ | 246-470 (h) | WB, IP, IF, ELISA | m, r, h | 14 | ||
γPAK Antikörper (E-9) | sc-373740 | mouse IgG2b κ | 497-522 (h) | WB, IP, IF, ELISA | m, r, h | 6 | ||
γPAK Antikörper (F-12) | sc-133113 | mouse IgG1 κ | 2-41 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
γPAK Antikörper (G-10) | sc-137208 | mouse IgG1 κ | 2-41 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
γPAK Antikörper (H-4) | sc-377194 | mouse IgG2a κ | 7-43 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
PAK4 Antikörper (B-3) | sc-390507 | mouse IgG1 κ | 167-209 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 11 | ||
PAK4 Antikörper (B-6) | sc-393367 | mouse IgG1 κ | 101-240 (h) | WB, IP, IF, ELISA | m, r, h | 5 | ||
PAK4 Antikörper (6C1) | sc-81532 | mouse IgG1 | (h) | WB, IP | m, r, h and canine | 1 | ||
PAK6 Antikörper (H-6) | sc-393075 | mouse IgG2b κ | 71-370 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 | ||
PAK6 Antikörper (C-2) | sc-393102 | mouse IgG2a κ | 71-370 (h) | WB, IP, IF, ELISA | h | 1 |
Phospho-Spezifische PAK Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
p-αPAK Antikörper (17.Thr 423) | sc-135755 | mouse IgG2b κ | Thr 423 (h) | WB, ELISA | m, r, h | 4 | ||
p-PAK4 Antikörper (93.Ser 474) | sc-135775 | mouse IgG2a κ | Ser 474 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 |
PAK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
αPAK CRISPR/Cas9 KO Plasmid (h2) | sc-400857-KO-2 | h | Gene Knockout | GFP | 1 | ||
αPAK HDR Plasmid (h2) | sc-400857-HDR-2 | h | Homology Directed Repair | Puromycin | 1 | ||
αPAK Double Nickase Plasmid (h) | sc-400857-NIC | h | Gene Knockout | Puromycin | 1 | ||
αPAK Double Nickase Plasmid (h2) | sc-400857-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
αPAK Double Nickase Plasmid (m) | sc-422107-NIC | m | Gene Knockout | Puromycin | 0 | ||
αPAK Double Nickase Plasmid (m2) | sc-422107-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
βPAK CRISPR/Cas9 KO Plasmid (h) | sc-401109 | h | Gene Knockout | GFP | 0 | ||
βPAK HDR Plasmid (h) | sc-401109-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
βPAK Double Nickase Plasmid (h) | sc-401109-NIC | h | Gene Knockout | Puromycin | 0 | ||
βPAK Double Nickase Plasmid (h2) | sc-401109-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
βPAK CRISPR/Cas9 KO Plasmid (m) | sc-422108 | m | Gene Knockout | GFP | 0 | ||
βPAK Double Nickase Plasmid (m) | sc-422108-NIC | m | Gene Knockout | Puromycin | 0 | ||
βPAK Double Nickase Plasmid (m2) | sc-422108-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
γPAK CRISPR/Cas9 KO Plasmid (h) | sc-401595 | h | Gene Knockout | GFP | 0 | ||
γPAK HDR Plasmid (h) | sc-401595-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
γPAK Double Nickase Plasmid (h) | sc-401595-NIC | h | Gene Knockout | Puromycin | 0 | ||
γPAK Double Nickase Plasmid (h2) | sc-401595-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
γPAK CRISPR/Cas9 KO Plasmid (m) | sc-432435 | m | Gene Knockout | GFP | 0 | ||
γPAK HDR Plasmid (m) | sc-432435-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
γPAK Double Nickase Plasmid (m) | sc-432435-NIC | m | Gene Knockout | Puromycin | 0 | ||
γPAK Double Nickase Plasmid (m2) | sc-432435-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PAK4 CRISPR/Cas9 KO Plasmid (h) | sc-401895 | h | Gene Knockout | GFP | 2 | ||
PAK4 HDR Plasmid (h) | sc-401895-HDR | h | Homology Directed Repair | Puromycin | 2 | ||
PAK4 Double Nickase Plasmid (h) | sc-401895-NIC | h | Gene Knockout | Puromycin | 2 | ||
PAK4 Double Nickase Plasmid (h2) | sc-401895-NIC-2 | h | Gene Knockout | Puromycin | 2 | ||
PAK4 CRISPR/Cas9 KO Plasmid (m) | sc-427750 | m | Gene Knockout | GFP | 0 | ||
PAK4 HDR Plasmid (m) | sc-427750-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PAK4 Double Nickase Plasmid (m) | sc-427750-NIC | m | Gene Knockout | Puromycin | 0 | ||
PAK4 Double Nickase Plasmid (m2) | sc-427750-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PAK5 CRISPR/Cas9 KO Plasmid (h) | sc-404073 | h | Gene Knockout | GFP | 0 | ||
PAK5 HDR Plasmid (h) | sc-404073-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PAK5 Double Nickase Plasmid (h) | sc-404073-NIC | h | Gene Knockout | Puromycin | 0 | ||
PAK5 Double Nickase Plasmid (h2) | sc-404073-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PAK5 CRISPR/Cas9 KO Plasmid (m) | sc-433855 | m | Gene Knockout | GFP | 0 | ||
PAK5 HDR Plasmid (m) | sc-433855-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PAK5 Double Nickase Plasmid (m) | sc-433855-NIC | m | Gene Knockout | Puromycin | 0 | ||
PAK5 Double Nickase Plasmid (m2) | sc-433855-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PAK6 CRISPR/Cas9 KO Plasmid (h) | sc-403345 | h | Gene Knockout | GFP | 0 | ||
PAK6 HDR Plasmid (h) | sc-403345-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PAK6 Double Nickase Plasmid (h) | sc-403345-NIC | h | Gene Knockout | Puromycin | 0 | ||
PAK6 Double Nickase Plasmid (h2) | sc-403345-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PAK6 CRISPR/Cas9 KO Plasmid (m) | sc-431921 | m | Gene Knockout | GFP | 0 | ||
PAK6 HDR Plasmid (m) | sc-431921-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PAK6 Double Nickase Plasmid (m) | sc-431921-NIC | m | Gene Knockout | Puromycin | 0 | ||
PAK6 Double Nickase Plasmid (m2) | sc-431921-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PAK CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
αPAK CRISPR Activation Plasmid (h) | sc-400857-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK CRISPR Activation Plasmid (h2) | sc-400857-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK Lentiviral Activation Particles (h) | sc-400857-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK Lentiviral Activation Particles (h2) | sc-400857-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
αPAK CRISPR Activation Plasmid (m) | sc-422107-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
αPAK CRISPR Activation Plasmid (m2) | sc-422107-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
αPAK Lentiviral Activation Particles (m) | sc-422107-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
αPAK Lentiviral Activation Particles (m2) | sc-422107-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK CRISPR Activation Plasmid (h) | sc-401109-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
/%base_sku__display_name%/ CRISPR Activation Plasmid (h2) | sc-401109-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (h) | sc-401109-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (h2) | sc-401109-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK CRISPR Activation Plasmid (m) | sc-422108-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK CRISPR Activation Plasmid (m2) | sc-422108-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (m) | sc-422108-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
βPAK Lentiviral Activation Particles (m2) | sc-422108-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activation Plasmid (h) | sc-401595-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activation Plasmid (h2) | sc-401595-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (h) | sc-401595-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (h2) | sc-401595-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activation Plasmid (m) | sc-432435-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK CRISPR Activation Plasmid (m2) | sc-432435-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (m) | sc-432435-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γPAK Lentiviral Activation Particles (m2) | sc-432435-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 CRISPR Activation Plasmid (h) | sc-401895-ACT | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 CRISPR Activation Plasmid (h2) | sc-401895-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 Lentiviral Activation Particles (h) | sc-401895-LAC | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 Lentiviral Activation Particles (h2) | sc-401895-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
PAK4 CRISPR Activation Plasmid (m) | sc-427750-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 CRISPR Activation Plasmid (m2) | sc-427750-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 Lentiviral Activation Particles (m) | sc-427750-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK4 Lentiviral Activation Particles (m2) | sc-427750-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activation Plasmid (h) | sc-404073-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activation Plasmid (h2) | sc-404073-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (h) | sc-404073-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (h2) | sc-404073-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activation Plasmid (m) | sc-433855-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 CRISPR Activation Plasmid (m2) | sc-433855-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (m) | sc-433855-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK5 Lentiviral Activation Particles (m2) | sc-433855-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activation Plasmid (h) | sc-403345-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activation Plasmid (h2) | sc-403345-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (h) | sc-403345-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (h2) | sc-403345-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activation Plasmid (m) | sc-431921-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 CRISPR Activation Plasmid (m2) | sc-431921-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (m) | sc-431921-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PAK6 Lentiviral Activation Particles (m2) | sc-431921-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
PAK siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
αPAK siRNA (h) | sc-29700 | h | Gene Silencing | N/A | 19 | ||
αPAK shRNA Plasmid (h) | sc-29700-SH | h | Gene Silencing | Puromycin | 19 | ||
αPAK shRNA (h) Lentivirale Partikel | sc-29700-V | h | Gene Silencing | Puromycin | 19 | ||
αPAK siRNA (m) | sc-29701 | m | Gene Silencing | N/A | 1 | ||
αPAK shRNA Plasmid (m) | sc-29701-SH | m | Gene Silencing | Puromycin | 1 | ||
αPAK shRNA (m) Lentivirale Partikel | sc-29701-V | m | Gene Silencing | Puromycin | 1 | ||
αPAK siRNA (r) | sc-270016 | r | Gene Silencing | N/A | 1 | ||
βPAK siRNA (h) | sc-36181 | h | Gene Silencing | N/A | 1 | ||
βPAK shRNA Plasmid (h) | sc-36181-SH | h | Gene Silencing | Puromycin | 1 | ||
βPAK shRNA (h) Lentivirale Partikel | sc-36181-V | h | Gene Silencing | Puromycin | 1 | ||
βPAK siRNA (m) | sc-36182 | m | Gene Silencing | N/A | 1 | ||
βPAK shRNA Plasmid (m) | sc-36182-SH | m | Gene Silencing | Puromycin | 1 | ||
βPAK shRNA (m) Lentivirale Partikel | sc-36182-V | m | Gene Silencing | Puromycin | 1 | ||
γPAK siRNA (h) | sc-36183 | h | Gene Silencing | N/A | 4 | ||
γPAK shRNA Plasmid (h) | sc-36183-SH | h | Gene Silencing | Puromycin | 4 | ||
γPAK shRNA (h) Lentivirale Partikel | sc-36183-V | h | Gene Silencing | Puromycin | 4 | ||
γPAK siRNA (m) | sc-36184 | m | Gene Silencing | N/A | 1 | ||
γPAK shRNA Plasmid (m) | sc-36184-SH | m | Gene Silencing | Puromycin | 1 | ||
γPAK shRNA (m) Lentivirale Partikel | sc-36184-V | m | Gene Silencing | Puromycin | 1 | ||
PAK4 siRNA (h) | sc-39060 | h | Gene Silencing | N/A | 9 | ||
PAK4 shRNA Plasmid (h) | sc-39060-SH | h | Gene Silencing | Puromycin | 9 | ||
PAK4 shRNA (h) Lentivirale Partikel | sc-39060-V | h | Gene Silencing | Puromycin | 9 | ||
PAK4 siRNA (m) | sc-39061 | m | Gene Silencing | N/A | 0 | ||
PAK4 shRNA Plasmid (m) | sc-39061-SH | m | Gene Silencing | Puromycin | 0 | ||
PAK4 shRNA (m) Lentivirale Partikel | sc-39061-V | m | Gene Silencing | Puromycin | 0 | ||
PAK5 siRNA (h) | sc-39062 | h | Gene Silencing | N/A | 0 | ||
PAK5 shRNA Plasmid (h) | sc-39062-SH | h | Gene Silencing | Puromycin | 0 | ||
PAK5 shRNA (h) Lentivirale Partikel | sc-39062-V | h | Gene Silencing | Puromycin | 0 | ||
PAK5 siRNA (m) | sc-151996 | m | Gene Silencing | N/A | 0 | ||
PAK5 shRNA Plasmid (m) | sc-151996-SH | m | Gene Silencing | Puromycin | 0 | ||
PAK5 shRNA (m) Lentivirale Partikel | sc-151996-V | m | Gene Silencing | Puromycin | 0 | ||
PAK6 siRNA (h) | sc-39063 | h | Gene Silencing | N/A | 2 | ||
PAK6 shRNA Plasmid (h) | sc-39063-SH | h | Gene Silencing | Puromycin | 2 | ||
PAK6 shRNA (h) Lentivirale Partikel | sc-39063-V | h | Gene Silencing | Puromycin | 2 | ||
PAK6 siRNA (m) | sc-44879 | m | Gene Silencing | N/A | 2 | ||
PAK6 shRNA Plasmid (m) | sc-44879-SH | m | Gene Silencing | Puromycin | 2 | ||
PAK6 shRNA (m) Lentivirale Partikel | sc-44879-V | m | Gene Silencing | Puromycin | 2 |